IBDEI09K ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4415,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,4416,0)
 ;;=730.00^^37^429^13
 ;;^UTILITY(U,$J,358.3,4416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4416,1,3,0)
 ;;=3^730.00
 ;;^UTILITY(U,$J,358.3,4416,1,4,0)
 ;;=4^OSTEOMYELITIS
 ;;^UTILITY(U,$J,358.3,4416,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,4417,0)
 ;;=382.9^^37^429^14
 ;;^UTILITY(U,$J,358.3,4417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4417,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,4417,1,4,0)
 ;;=4^OTITIS MEDIA NOS
 ;;^UTILITY(U,$J,358.3,4417,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,4418,0)
 ;;=614.9^^37^429^15
 ;;^UTILITY(U,$J,358.3,4418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4418,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,4418,1,4,0)
 ;;=4^PELVIC INFLAMMATORY DISEASE
 ;;^UTILITY(U,$J,358.3,4418,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,4419,0)
 ;;=462.^^37^429^16
 ;;^UTILITY(U,$J,358.3,4419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4419,1,3,0)
 ;;=3^462.
 ;;^UTILITY(U,$J,358.3,4419,1,4,0)
 ;;=4^PHARYNGITIS
 ;;^UTILITY(U,$J,358.3,4419,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,4420,0)
 ;;=486.^^37^429^17
 ;;^UTILITY(U,$J,358.3,4420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4420,1,3,0)
 ;;=3^486.
 ;;^UTILITY(U,$J,358.3,4420,1,4,0)
 ;;=4^PNEUMONIA
 ;;^UTILITY(U,$J,358.3,4420,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,4421,0)
 ;;=590.80^^37^429^18
 ;;^UTILITY(U,$J,358.3,4421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4421,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,4421,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,4421,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,4422,0)
 ;;=711.00^^37^429^19
 ;;^UTILITY(U,$J,358.3,4422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4422,1,3,0)
 ;;=3^711.00
 ;;^UTILITY(U,$J,358.3,4422,1,4,0)
 ;;=4^SEPTIC JOINT
 ;;^UTILITY(U,$J,358.3,4422,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,4423,0)
 ;;=461.8^^37^429^20
 ;;^UTILITY(U,$J,358.3,4423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4423,1,3,0)
 ;;=3^461.8
 ;;^UTILITY(U,$J,358.3,4423,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,4423,2)
 ;;=^269865
 ;;^UTILITY(U,$J,358.3,4424,0)
 ;;=473.8^^37^429^21
 ;;^UTILITY(U,$J,358.3,4424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4424,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,4424,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,4424,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,4425,0)
 ;;=463.^^37^429^22
 ;;^UTILITY(U,$J,358.3,4425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4425,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,4425,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,4425,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,4426,0)
 ;;=011.90^^37^429^23
 ;;^UTILITY(U,$J,358.3,4426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4426,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,4426,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,4426,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,4427,0)
 ;;=465.9^^37^429^24
 ;;^UTILITY(U,$J,358.3,4427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4427,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,4427,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,4427,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,4428,0)
 ;;=599.0^^37^429^25
 ;;^UTILITY(U,$J,358.3,4428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4428,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,4428,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,4428,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,4429,0)
 ;;=616.10^^37^429^26
 ;;^UTILITY(U,$J,358.3,4429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4429,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,4429,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,4429,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,4430,0)
 ;;=277.30^^37^430^1
 ;;^UTILITY(U,$J,358.3,4430,1,0)
 ;;=^358.31IA^4^2
